These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Comparison of p63 and p40 (ΔNp63) as Basal, Squamoid, and Myoepithelial Markers in Salivary Gland Tumors. Owosho AA; Aguilar CE; Seethala RR Appl Immunohistochem Mol Morphol; 2016 Aug; 24(7):501-8. PubMed ID: 26230372 [TBL] [Abstract][Full Text] [Related]
4. Comparison of p40 (ΔNp63) and p63 expression in prostate tissues--which one is the superior diagnostic marker for basal cells? Sailer V; Stephan C; Wernert N; Perner S; Jung K; Dietel M; Kristiansen G Histopathology; 2013 Jul; 63(1):50-6. PubMed ID: 23668398 [TBL] [Abstract][Full Text] [Related]
5. Tumour 63 protein (p63) in breast pathology: biology, immunohistochemistry, diagnostic applications, and pitfalls. Alkhayyat R; Abbas A; Quinn CM; Rakha EA Histopathology; 2024 Apr; 84(5):723-741. PubMed ID: 38012539 [TBL] [Abstract][Full Text] [Related]
6. p63 isoforms in triple-negative breast cancer: ΔNp63 associates with the basal phenotype whereas TAp63 associates with androgen receptor, lack of BRCA mutation, PTEN and improved survival. Coates PJ; Nenutil R; Holcakova J; Nekulova M; Podhorec J; Svoboda M; Vojtesek B Virchows Arch; 2018 Mar; 472(3):351-359. PubMed ID: 29484502 [TBL] [Abstract][Full Text] [Related]
7. Characterization of specific p63 and p63-N-terminal isoform antibodies and their application for immunohistochemistry. Nekulova M; Holcakova J; Nenutil R; Stratmann R; Bouchalova P; Müller P; Mouková L; Coates PJ; Vojtesek B Virchows Arch; 2013 Sep; 463(3):415-25. PubMed ID: 23887585 [TBL] [Abstract][Full Text] [Related]
8. p40 (ΔNp63) is more specific than p63 and cytokeratin 5 in identifying squamous cell carcinoma of bronchopulmonary origin: a review and comparative analysis. Vogt AP; Cohen C; Siddiqui MT Diagn Cytopathol; 2014 May; 42(5):453-8. PubMed ID: 24166777 [TBL] [Abstract][Full Text] [Related]
9. An immunohistochemical analysis of a newly developed, mouse monoclonal p40 (BC28) antibody in lung, bladder, skin, breast, prostate, and head and neck cancers. Tacha D; Bremer R; Haas T; Qi W Arch Pathol Lab Med; 2014 Oct; 138(10):1358-64. PubMed ID: 24528495 [TBL] [Abstract][Full Text] [Related]
10. Expression of the p40 isoform of p63 has high specificity for cutaneous sarcomatoid squamous cell carcinoma. Ha Lan TT; Chen SJ; Arps DP; Fullen DR; Patel RM; Siddiqui J; Carskadon S; Palanisamy N; Harms PW J Cutan Pathol; 2014 Nov; 41(11):831-8. PubMed ID: 25263756 [TBL] [Abstract][Full Text] [Related]
11. Immunostaining of ∆Np63 (using the p40 antibody) is equal to that of p63 and CK5/6 in high-grade ductal carcinoma in situ of the breast. Sailer V; Lüders C; Kuhn W; Pelzer V; Kristiansen G Virchows Arch; 2015 Jul; 467(1):67-70. PubMed ID: 25850754 [TBL] [Abstract][Full Text] [Related]
12. P40 Immunostain Does Not Outperform p63 as a Myoepithelial Cell Marker in the Daily Practice of Breast Pathology. Khazai L; Agosto-Arroyo E; Rosa M Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):599-604. PubMed ID: 28549030 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical Detection of p40 Expression in Lung Cancer Clinical Samples. Nambirajan A; Jain D Methods Mol Biol; 2021; 2279():13-21. PubMed ID: 33683682 [TBL] [Abstract][Full Text] [Related]
14. p40 is a more specific marker than p63 for cutaneous poorly differentiated squamous cell carcinoma. Alomari AK; Glusac EJ; McNiff JM J Cutan Pathol; 2014 Nov; 41(11):839-45. PubMed ID: 25263848 [TBL] [Abstract][Full Text] [Related]
15. p40 (ΔNp63) expression in breast disease and its correlation with p63 immunohistochemistry. Kim SK; Jung WH; Koo JS Int J Clin Exp Pathol; 2014; 7(3):1032-41. PubMed ID: 24696720 [TBL] [Abstract][Full Text] [Related]
16. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas. Edwards PC; Bhuiya T; Kelsch RD Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May; 97(5):613-9. PubMed ID: 15153875 [TBL] [Abstract][Full Text] [Related]
17. Benign and malignant odontogenic neoplasms of the jaws show a concordant nondiscriminatory p63/p40 positive immunophenotype. Argyris PP; Malz C; Taleb R; Koutlas IG Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Dec; 126(6):506-512. PubMed ID: 30309829 [TBL] [Abstract][Full Text] [Related]
18. A study of ΔNp63 expression in lung non-small cell carcinomas. Nonaka D Am J Surg Pathol; 2012 Jun; 36(6):895-9. PubMed ID: 22367298 [TBL] [Abstract][Full Text] [Related]
19. Pan-p63 but not ΔNp63 (p40) expression in undifferentiated carcinoma of the pancreas. Liszka Ł Pol J Pathol; 2020; 71(2):155-172. PubMed ID: 32729306 [TBL] [Abstract][Full Text] [Related]
20. TAp63 and ΔNp63 (p40) in prostate adenocarcinomas: ΔNp63 associates with a basal-like cancer stem cell population but not with metastasis. Galoczova M; Nenutil R; Pokorna Z; Vojtesek B; Coates PJ Virchows Arch; 2021 Apr; 478(4):627-636. PubMed ID: 33037932 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]